Interestingly, the anti-phagocytosis marker SIRPα (CD172a) was increased on phagocytic CD91+ macrophages and CD1a+ dendritic cells in cases versus controls in the proliferative phase, suggesting decreased phagocytic capacity of these populations in endometriosis patients. This evidence concerns the gene SIRPA and endometriosis.